indican has been researched along with Cardiomyopathy, Hypertrophic Obstructive in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amaki, M; Fukuda, H; Hasegawa, T; Hitsumoto, T; Imazu, M; Ito, S; Kanzaki, H; Kitakaze, M; Morita, T; Takahama, H; Tsukamoto, O | 1 |
| Adrahtas, A; Kelly, DJ; Kompa, AR; Krum, H; Lekawanvijit, S; Wang, BH | 1 |
2 other study(ies) available for indican and Cardiomyopathy, Hypertrophic Obstructive
| Article | Year |
|---|---|
Plasma indoxyl sulfate levels predict cardiovascular events in patients with mild chronic heart failure.
Topics: Adult; Aged; Biomarkers; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic; Cardiovascular Physiological Phenomena; Chronic Disease; Female; Heart Failure; Humans; Indican; Kaplan-Meier Estimate; Male; Middle Aged; Plasma; Prognosis; Ventricular Dysfunction, Left | 2020 |
Does indoxyl sulfate, a uraemic toxin, have direct effects on cardiac fibroblasts and myocytes?
Topics: Animals; Blotting, Western; Cardiomyopathy, Hypertrophic; Cell Survival; Cells, Cultured; Cytokines; Dose-Response Relationship, Drug; Fibroblasts; Indican; Kidney Failure, Chronic; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; RNA, Messenger; Toxins, Biological | 2010 |